Valeant Pharmaceuticals, Sanitas Group deal

Valeant will acquire Lithuanian branded generics company Sanitas for about €314 million ($440.2 million) in cash. Valeant

Read the full 179 word article

How to gain access

Continue reading with a
two-week free trial.